ZOSYN

This brand name is authorized in United States. It is also authorized in Japan.

Active ingredients

The drug ZOSYN contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII UXA545ABTT - TAZOBACTAM SODIUM
 

Tazobactam is a beta-lactam structurally related to penicillins. It is an inhibitor of many molecular Class A beta-lactamases, including CTX-M, SHV, and TEM enzymes.

 
Read more about Tazobactam
2
UNII M98T69Q7HP - PIPERACILLIN SODIUM
 

Piperacillin is a broad-spectrum, semisynthetic penicillin. Piperacillin exerts bactericidal activity by inhibition of both septum and cell-wall synthesis.

 
Read more about Piperacillin

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
JP 医薬品医療機器総合機構 6139505F3020, 6139505F4026, 6139505G1022
US FDA, National Drug Code 0206-8860, 0206-8861, 0206-8862

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.